![](https://timesofindia.indiatimes.com/photo/79947424.cms)
ndo Pharma Limited has inked an exclusive licence agreement with US-based COVAXX to develop, commercialise and manufacture the latter’s UB-612 Covid-19 vaccine candidate for India and the United Nations Children's Fund (UNICEF).
from Hyderabad News: Latest Hyderabad News Headlines & Live News Updates from Hyderabad - Times of India https://ift.tt/3mM4hp9
Comments
Post a Comment